| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.092 | 0.001 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |